Duncan Whitney promoted to senior VP at Allegro
This article was originally published in Scrip
Allegro Diagnostics, a molecular diagnostics company developing innovative genomic tests for the diagnosis, staging and informed treatment of lung cancer and other lung diseases, has appointed Dr Duncan Whitney senior vice-president of research and development. Dr Whitney joined Allegro in January 2010 having previously served as chief scientific officer of Progenika, a microarray-based clinical diagnostics company.